{
  "content": "Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.Qin D, Leef G, Alam MB, Rattan R, Munir MB, Patel D, Khattak F, Adelstein E, Jain SK, Saba S.Qin D, et al.J Cardiol. 2016 May;67(5):471-6. doi: 10.1016/j.jjcc.2015.07.001. Epub 2015 Jul 29.J Cardiol. 2016.PMID: 26233885  \nAmiodarone after surgical ablation for atrial fibrillation: Is it really necessary? A prospective randomized controlled trial.Ad N, Holmes SD, Shuman DJ, Pritchard G, Miller CE.Ad N, et al.J Thorac Cardiovasc Surg. 2016 Mar;151(3):798-803. doi: 10.1016/j.jtcvs.2015.07.034. Epub 2015 Jul 17.J Thorac Cardiovasc Surg. 2016.PMID: 26253874 Clinical Trial.",
  "source": "https://pubmed.ncbi.nlm.nih.gov/26412606/",
  "chunk_id": "5e43f866-8b50-4d10-8f7d-5ec0958672fb",
  "similarity_score": 0.4726420044898987,
  "query": "amiodarone versus beta-blockers atrial fibrillation randomized controlled trial effectiveness rhythm control rate control",
  "rank": 3,
  "title": "Mortality risk of long-term amiodarone therapy for atrial fibrillation patients without structural heart disease",
  "authors": "Dingxin Qin, George Leef, Mian Bilal Alam, Rohit Rattan, Mohamad Bilal Munir, Divyang Patel, Furqan Khattak, Evan Adelstein, Sandeep K Jain, Samir Saba",
  "year": "2015",
  "journal": "Cardiology Journal",
  "reference": "Qin, D., Leef, G., Alam, M. B., Rattan, R., Munir, M. B., Patel, D., Khattak, F., Adelstein, E., Jain, S. K., & Saba, S. (2015). Mortality risk of long-term amiodarone therapy for atrial fibrillation patients without structural heart disease. Cardiology Journal, 22(6), 622-629. https://doi.org/10.5603/CJ.a2015.0055",
  "doi": "10.5603/CJ.a2015.0055",
  "chunk_index": 10,
  "total_chunks": 20,
  "retrieved_at": "2025-07-24T21:57:43.521090"
}